Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer

dc.contributor.authorLawal, Ismaheel Opeyemi
dc.contributor.authorMorgenstern, Alfred
dc.contributor.authorVorster, Mariza
dc.contributor.authorKnoesen, Otto
dc.contributor.authorMahapane, Johncy
dc.contributor.authorHlongwa, Khanyisile N.
dc.contributor.authorMaserumule, Letjie C.
dc.contributor.authorNdlovu, Honest
dc.contributor.authorReed, Janet D.
dc.contributor.authorPopoola, Gbenga O.
dc.contributor.authorMokoala, Kgomotso M.G.
dc.contributor.authorMdlophane, A.H.
dc.contributor.authorBruchertseifer, Frank
dc.contributor.authorSathekge, Mike Machaba
dc.contributor.emailmike.sathekge@up.ac.zaen_US
dc.date.accessioned2022-07-22T08:53:13Z
dc.date.issued2022-08
dc.description.abstractPlease read abstract in the article.en_US
dc.description.departmentNuclear Medicineen_US
dc.description.departmentRadiographyen_US
dc.description.embargo2023-04-06
dc.description.librariandm2022en_US
dc.description.urihttps://www.springer.com/journal/259en_US
dc.identifier.citationLawal, I.O., Morgenstern, A., Vorster, M. et al. Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 49, 3581–3592 (2022). https://doi.org/10.1007/s00259-022-05778-w.en_US
dc.identifier.issn1619-7089 (online)
dc.identifier.issn1619-7070 (print)
dc.identifier.other10.1007/s00259-022-05778-w
dc.identifier.urihttps://repository.up.ac.za/handle/2263/86396
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.rights© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. The original publication is available at : https://www.springer.com/journal/259.en_US
dc.subjectTargeted alpha therapyen_US
dc.subjectSuperscanen_US
dc.subjectSkeletal metastasesen_US
dc.subjectProstate canceren_US
dc.subjectHematologic toxicityen_US
dc.subjectMetastatic castration-resistant prostate cancer (mCRPC)en_US
dc.subjectActinium-225-labeled prostate-specific membrane antigen ([225Ac]Ac-PSMA-617)en_US
dc.titleHematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate canceren_US
dc.typePostprint Articleen_US

Files

Original bundle

Now showing 1 - 3 of 3
Thumbnail Image
Name:
Lawal_Hematologic_2022.pdf
Size:
548.97 KB
Format:
Adobe Portable Document Format
Description:
Postprint Article
Download
Thumbnail Image
Name:
Lawal_HematologicSupplFig_2022.pdf
Size:
118.89 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Figure
Download
Thumbnail Image
Name:
Lawal_HematologicSupplTabs_2022.pdf
Size:
69.51 KB
Format:
Adobe Portable Document Format
Description:
Supplementary Tables
Download

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (Nuclear Medicine)
Research Articles (Radiography)
Research Articles (University of Pretoria)
Simple item page